CL2014000033A1 - Fago geneticamente modificado con un sistema de expresion; genes s, r y/o q, lnt y/o xis son inactivados; y uso del mismo. - Google Patents

Fago geneticamente modificado con un sistema de expresion; genes s, r y/o q, lnt y/o xis son inactivados; y uso del mismo.

Info

Publication number
CL2014000033A1
CL2014000033A1 CL2014000033A CL2014000033A CL2014000033A1 CL 2014000033 A1 CL2014000033 A1 CL 2014000033A1 CL 2014000033 A CL2014000033 A CL 2014000033A CL 2014000033 A CL2014000033 A CL 2014000033A CL 2014000033 A1 CL2014000033 A1 CL 2014000033A1
Authority
CL
Chile
Prior art keywords
lnt
inactivated
genetically modified
expression system
phage
Prior art date
Application number
CL2014000033A
Other languages
English (en)
Inventor
Cedric Szpirer
Original Assignee
Delphi Genetics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11173033A external-priority patent/EP2543720A1/en
Priority claimed from US13/178,402 external-priority patent/US9920323B2/en
Application filed by Delphi Genetics filed Critical Delphi Genetics
Publication of CL2014000033A1 publication Critical patent/CL2014000033A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00088—Details for redistribution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CL2014000033A 2011-07-07 2014-01-07 Fago geneticamente modificado con un sistema de expresion; genes s, r y/o q, lnt y/o xis son inactivados; y uso del mismo. CL2014000033A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11173033A EP2543720A1 (en) 2011-07-07 2011-07-07 Genetically modified phage and use thereof
US13/178,402 US9920323B2 (en) 2011-07-07 2011-07-07 Genetically modified phage and use thereof

Publications (1)

Publication Number Publication Date
CL2014000033A1 true CL2014000033A1 (es) 2014-12-12

Family

ID=46458540

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000033A CL2014000033A1 (es) 2011-07-07 2014-01-07 Fago geneticamente modificado con un sistema de expresion; genes s, r y/o q, lnt y/o xis son inactivados; y uso del mismo.

Country Status (10)

Country Link
EP (1) EP2729563B1 (es)
JP (2) JP6174019B2 (es)
CN (1) CN103797113B (es)
AR (1) AR087330A1 (es)
BR (1) BR112014000248B1 (es)
CA (1) CA2841805C (es)
CL (1) CL2014000033A1 (es)
ES (1) ES2699652T3 (es)
IN (1) IN2014MN00024A (es)
WO (1) WO2013004817A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3172334B1 (en) 2014-07-25 2021-11-10 R.P. Scherer Technologies, LLC Improved host cell for producing proteins
JP6779513B2 (ja) * 2016-07-11 2020-11-04 大学共同利用機関法人情報・システム研究機構 インビボクローニング可能な細胞株をスクリーニングするための方法、インビボクローニング可能な細胞株の製造方法、細胞株、インビボクローニング方法、及びインビボクローニングを行うためのキット
CN119799656B (zh) * 2025-01-07 2025-10-10 青岛农业大学 一种防治马流产沙门菌的噬菌体组合物、生物制剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952496A (en) * 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US7153652B2 (en) * 1995-10-02 2006-12-26 The Board Of Trustees Of The Leland Stanford Junior University Mismatch repair detection
US6355412B1 (en) 1999-07-09 2002-03-12 The European Molecular Biology Laboratory Methods and compositions for directed cloning and subcloning using homologous recombination
EP1309604B1 (en) * 2000-08-15 2007-03-28 Phage Biotechnology Corporation Phage-dependent superproduction of biologically active protein and peptides
US8470580B2 (en) 2001-02-23 2013-06-25 Universite Libre De Bruxelles Method for the selection of recombination clones comprising a sequence encoding an antidote protein to a toxic molecule
BR0214542A (pt) 2001-12-12 2005-08-16 Lilly Co Eli Célula hospedeira, sistema de expressão, e, processos de preparação de uma célula hospedeira, e de uma proteìna alvo
US20090311742A1 (en) * 2005-02-22 2009-12-17 David Tabaczynski Phage-Derived Vectors and Methods for Protein Expression
GB0709061D0 (en) 2007-05-11 2007-06-20 Avecia Biolog Ltd Expression system

Also Published As

Publication number Publication date
BR112014000248A2 (pt) 2017-07-11
JP6174019B2 (ja) 2017-08-02
BR112014000248B1 (pt) 2021-01-19
EP2729563A1 (en) 2014-05-14
WO2013004817A1 (en) 2013-01-10
CN103797113A (zh) 2014-05-14
CA2841805C (en) 2020-12-15
CA2841805A1 (en) 2013-01-10
IN2014MN00024A (es) 2015-06-12
AR087330A1 (es) 2014-03-19
CN103797113B (zh) 2018-08-10
ES2699652T3 (es) 2019-02-12
JP2014520519A (ja) 2014-08-25
EP2729563B1 (en) 2018-09-12
JP2017158551A (ja) 2017-09-14

Similar Documents

Publication Publication Date Title
CL2018000813A1 (es) Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso.
IL252039A0 (en) Sending and receiving payments using a message system
IL252796B (en) Therapeutic, diagnostic and prognostic methods for cancer of the bladder
BR112017007160A2 (pt) sistemas de catalisador de fosfinimida de titânio e de iminoimidazolidida de titânio com suportes de ativador.
BR112016027039A2 (pt) caneta apontadora e sistema de carregamento de caneta apontadora
IL246837B (en) Antibodies, pharmaceutical compositions and uses thereof
DK3143138T3 (da) Betinget aktive biologiske proteiner
MX384024B (es) Peptidos macrociclicos utiles como inmunomoduladores.
EP3355980A4 (en) CATHETER STRUCTURE WITH IMPROVED CARRIER AND ASSOCIATED SYSTEMS, METHODS AND DEVICES
DK3027208T3 (da) Cancerdiagnose og -terapi, der involverer cancerstamceller
BR112016029207A2 (pt) resinas de polietileno
FI3265123T3 (fi) Vasta-aineita, käyttöjä & menetelmiä
LT3167065T (lt) Dviguba cistroninė bakterinė raiškos sistema
FR3025438B1 (fr) Regenerateur de catalyseurs.
LT3191514T (lt) Ligandai, sustiprinantys gonadotropinų biologinį aktyvumą
FI20155955L (fi) Mikrobinen polttokenno, sen käyttö ja mikrobinen polttokennojärjestelmä
BR112015023685A2 (pt) sistema, e método.
EP2904012A4 (en) ANDROGEN SUPPRESSION, PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND CONCEPT FOR CONDITIONALLY REINFORCED VULNERABILITY
MY180166A (en) Cosmic quenchers
BR112016028197A2 (pt) sistema de expressão de genes
DK3206733T3 (da) Leveringssystem og driftsmodus
EP3368215A4 (en) ACID-RESISTANT CATALYST SUPPLEMENTS AND CATALYSTS
CL2014000033A1 (es) Fago geneticamente modificado con un sistema de expresion; genes s, r y/o q, lnt y/o xis son inactivados; y uso del mismo.
BR112015003691A2 (pt) métodos e sistema.
BR112017012087A2 (pt) métodos de identificação de genes codificantes e não codificantes coexpressados, e sistema